Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway

Fig. 2

Basic information and characteristics of circPTPN22. a Location and formation of circPTPN22. b The primer length of circPTPN22 was verified by agarose gel electrophoresis. c Sanger sequencing detects the cyclization sites. d Verify circPTPN22 circular structure. e RNase R assay verified the tolerance of circPTPN22 to exonuclease. f Actinomycin D assay verified the half-life of circPTPN22 in BGC-823 cell. g The expression levels of circPTPN22 and its transcription gene PTPN22 in plasma of 20 GC patients and 20 healthy donors. h The expression levels of circPTPN22 in plasma of 20 ESCC, CRC, CC, LC patients and 20 healthy donors

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us